MIR3129

Across TCGA pan-cancer cohorts, MIR3129 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MIR3129 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR3129 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3129 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

KIRC, BRCA, and LGG are the cancer types where MIR3129 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.625	0.819	.007	48	view →
BRCA	DFS	Tertile	III,IV	0.755	0.891	.020	39	view →
LGG	OS	Tertile	All	0.377	0.812	.008	36	view →
MESO	OS	Tertile	III,IV	0.370	0.620	.005	30	view →
SARC	DFS	Tertile	All	0.396	0.661	.003	21	view →
BLCA	OS	Tertile	IV	0.435	0.618	.022	18	view →
THCA	OS	Tertile	IV	0.720	1.000	.004	18	view →
ACC	DFS	Tertile	II,III,IV	0.242	0.724	.034	18	view →
HNSC	DFS	Tertile	III,IV	0.424	0.615	.009	12	view →
OV	DFS	Quartile	IV	0.288	0.572	.003	8	view →
SKCM	OS	Tertile	II,III,IV	0.951	0.722	.020	6	view →
STAD	OS	Quartile	IV	0.292	0.754	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MIR3129–KIRC (DFS)

Open the KIRC breakdown →